Quipt Home Medical Corp T.QIPT

Alternate Symbol(s): QIPT

Healthcare

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.

TSX:QIPT - Post by User

Quipt Home Medical Corp > HME news article: Good or Bad for Quipt....Hmmmmmmmm

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jul 25, 2024 12:44pm

130 Views

Post# 36148262

RE:RE:HME news article: Good or Bad for Quipt....Hmmmmmmmm

6.3 x $60M ebitda = $378M enterprise value for Quipt.

less $50M net debt = $328M equity value

47M diluted shares => $6.98 US per share.

lscfa wrote: "Rotech generated about $750 million of revenue and an EBITDA margin of nearly 30% in 2023."

"the net purchase price is about $1.32 billion, representing 6.3x multiple of LTM EBITDA, excluding synergies."

old Rotech prospectus shows:
- 2020 revenues of $503.2M,
- ebitda of $152.6M and
- ebitda-less-patient-capex of $99.3M
- ebitda margin of 30.3%
- ebitda-less-patient-capex margin of 19.7%

Purchase price is 6.3 x ebitda, so ~ 9.7 x ebitda-less-patient-capex